Artikel ; Online: Cost and health impact analysis of herpes zoster vaccination in Norway.
Expert review of pharmacoeconomics & outcomes research
2021 Band 22, Heft 2, Seite(n) 315–326
Abstract: Background: A decision analytic model was developed to estimate the cost-effectiveness of a national vaccination program against herpes zoster in Norway.: Methods: The model analyzed six vaccination scenarios that included the live-attenuated zoster ... ...
Abstract | Background: A decision analytic model was developed to estimate the cost-effectiveness of a national vaccination program against herpes zoster in Norway. Methods: The model analyzed six vaccination scenarios that included the live-attenuated zoster vaccine under different target ages of vaccination (60, 65, and 70 years) compared with no vaccination. A catch-up program implemented in the first year of the vaccination was included in three of the scenarios. The model followed the population of Norway over a 40-year time horizon to estimate costs and outcomes associated with vaccination. Immunization costs, costs related to herpes zoster (both healthcare sector and non-healthcasre sector), the quality of life gains due to avoided cases of herpes zoster, and quality-of-life losses due to vaccine-related adverse events were estimated. Results and conclusions: A national vaccination program would result in reduction of the number of herpes zoster cases and decreased burden of illness. Vaccinating adults at 65 years of age with catch-up up to 70 years in the first year of the program was the most cost-effective strategy with the incremental cost per quality-adjusted life-year gained at NOK (Norwegian Krone) 245,459 from the societal perspective and NOK 248,637 from the health care system perspective. |
---|---|
Mesh-Begriff(e) | Cost-Benefit Analysis ; Herpes Zoster/epidemiology ; Herpes Zoster/prevention & control ; Herpes Zoster Vaccine ; Humans ; Quality of Life ; Quality-Adjusted Life Years ; Vaccination |
Chemische Substanzen | Herpes Zoster Vaccine |
Sprache | Englisch |
Erscheinungsdatum | 2021-09-12 |
Erscheinungsland | England |
Dokumenttyp | Journal Article |
ZDB-ID | 2208481-2 |
ISSN | 1744-8379 ; 1473-7167 |
ISSN (online) | 1744-8379 |
ISSN | 1473-7167 |
DOI | 10.1080/14737167.2021.1973893 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 6194: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.